logo


CompuMed Inc. Teams with University of Miami Miller School of Medicine To Provide Landmark Pediatric ECG Services
Thursday, January 29, 2009 8:10 AM


CompuMed Will Launch CardioGramKids™, Critical Screening Program for Children at Risk of Cardiovascular Problems Due to Psychotropic Medications, Including Stimulants for ADHD and Other Conditions

CompuMed, Inc. (OTCBB: CMPD) (www.compumed.net) today announced a landmark program in pediatric screening services, CardioGramKids™, teaming with the highly respected Department of Pediatrics at the University of Miami Miller School of Medicine to provide electrocardiogram (ECG) screening services to children and teenagers prior to prescribing or taking psychotropic medications, including stimulants. CompuMed will remotely interpret ECGs on pediatric patients in this first-of-its-kind program to detect heart abnormalities prior to therapy. CompuMed and the University of Miami have launched this program in response to the American Heart Association and other leading groups that have expressed concern regarding reports of sudden death in children and adolescents treated with stimulants and other psychotropic medications for conditions such as attention deficit hyperactivity disorder, commonly referred to as ADHD. Medical journals have long reported concerns regarding the appropriateness of such therapy without screening at risk patients.

“We are delighted, yet sobered, to be launching this important project with such an experienced pediatric cardiology partner,” said Maurizio Vecchione, CompuMed’s CEO. “For far too long, children have potentially been put at risk of developing or exacerbating potentially serious or life threatening cardiac conditions without prior ECG screenings. Unfortunately, today’s 12-lead ECG machines are complex, and more than 400 diagnoses can be made from a single ECG. Interpreting ECGs without specialized training, especially in pediatric cardiology, could lead to potentially life-threatening misdiagnoses. Additionally computerized interpretations are not necessarily optimized for pediatric studies and in general have significant error rates.

“This is the first of what we believe to be many partnerships with pediatric, psychiatric and primary care practices throughout the country aimed at saving children’s lives. Physicians can screen their pediatric patients with the confidence that specialist pediatric cardiologists are providing the interpretations,” Mr. Vecchione added.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia